Substance / Medication

Sumatriptan succinate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
Tayel Saadya A, El Nabarawi Mohamed A, Amin Maha M et al. · AAPS PharmSciTech · 2017
PMID: 27038484Observational
Thermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P-NMR analysis on negatively and positively-charged liposomes.
Villasmil-Sánchez Sheila, Rabasco Antonio M, González-Rodríguez M Luisa · Colloids Surf B Biointerfaces · 2013
PMID: 23352939Observational
Stability-indicating micellar electrokinetic chromatography method for the analysis of sumatriptan succinate in pharmaceutical formulations.
Al Azzam Khaldun M, Saad Bahruddin, Tat Chai Yuan et al. · J Pharm Biomed Anal · 2011
PMID: 21873014Observational
Mucoadhesive bilayered patches for administration of sumatriptan succinate.
Shidhaye Supriya S, Saindane Nilesh S, Sutar Sagar et al. · AAPS PharmSciTech · 2008
PMID: 18679806ObservationalFull text (PMC)
Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
Goldstein Jerome, Silberstein Stephen D, Saper Joel R et al. · Headache · 2005
PMID: 16109110Observational
Development and validation of an LC assay for sumatriptan succinate residues on surfaces in the manufacture of pharmaceuticals.
Nozal María J, Bernal José L, Toribio L et al. · J Pharm Biomed Anal · 2002
PMID: 12191714Observational
Formulation of sumatriptan succinate orodispersible tablets using chitosan and sodium starch glycolate for immediate migraine relief.
Sahar Tuba, Farid Hasan Syed Muhammad, Ahmad Salman Ashfaq et al. · Pak J Pharm Sci · 2024
PMID: 38741407Other
Preparation and Optimization of Liposome Containing ThermosensitiveNasal Hydrogel System for Brain Delivery of Sumatriptan Succinate.
Mathure Dyandevi, Sutar Ashish Dilip, Ranpise Hemantkumar et al. · Assay Drug Dev Technol · 2023
PMID: 36576871Other
Design and evaluation of sustained release mucoadhesive film of sumatriptan succinate containing grafted co-polymer as the platform.
Verma Surajpal, Tonk Rajiv Kumar, Albratty Mohammed et al. · Saudi Pharm J · 2022
PMID: 36465843OtherFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sumatriptan succinate (substance)
SNOMED CT
96215002
UMLS CUI
C0206599

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.